TrialCritical care (London, England)2016

The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial.

Marianne J Chapman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.